This study demonstrated that i.c.v. injection of TGF-β in the brains of mice mimicked clinical features of CFS, such as depression, anxiety, hypersensitivity to pain, and impaired learning memory accompanied with decreased dopamine production. Here, TGFB1 is linked to depressive disorder.